HomeINTS • NASDAQ
add
Intensity Therapeutics Inc
Previous close
$0.23
Day range
$0.23 - $0.25
Year range
$0.19 - $4.25
Market cap
11.51M USD
Avg Volume
4.62M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.70M | -46.64% |
Net income | -2.54M | 48.96% |
Net profit margin | — | — |
Earnings per share | -0.13 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.22M | -64.96% |
Total assets | 4.44M | -48.77% |
Total liabilities | 2.26M | -32.12% |
Total equity | 2.18M | — |
Shares outstanding | 47.06M | — |
Price to book | 2.90 | — |
Return on assets | -180.14% | — |
Return on capital | -487.56% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -2.54M | 48.96% |
Cash from operations | -2.46M | 41.72% |
Cash from investing | — | — |
Cash from financing | 3.74M | 124,666.67% |
Net change in cash | 1.29M | 130.52% |
Free cash flow | -1.61M | 31.00% |
About
Founded
2012
Headquarters
Website
Employees
5
